Acasti to participate in the h.c. wainwright global investment conference

Princeton, n.j., sept. 06, 2023 (globe newswire) -- acasti pharma inc. (nasdaq: acst) (acasti or the company), a late-stage, biopharma company advancing gtx-104, its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (asah), today announced that the company's management will be participating in the 25th annual h.c. wainwright global investment conference, to be held september 11-13 , 2023 in new york, ny.
ACST Ratings Summary
ACST Quant Ranking